Abstracts
Posters
P-140 - Preliminary results of a phase 1A/1B study of BGB-A317, an anti-PD-1 monoclonal antibody (mAb), in patients with advanced hepatocellular carcinoma (HCC)

https://doi.org/10.1093/annonc/mdx261.139Get rights and content
Under an Elsevier user license
open archive

Cited by (0)